Literature DB >> 20924729

Histiocytic sarcoma with two immunohistopathologically distinct populations.

Kanako Wakahashi1, Manabu Shimoyama, Yoshio Katayama, Kentaro Minagawa, Kenji Yoshida, Ryohei Sasaki, Shunji Nakayama, Hiroshi Yokozaki, Emmy Yanagita, Tomoo Itoh, Yoshitake Hayashi, Toshimitsu Matsui.   

Abstract

This report is a case of histiocytic sarcoma (HS), in which tumor cells consist of two immunohistopathologically distinct populations (A) oval CD68+lysozyme+CD163- cells and (B) abundant cytoplasm or spindle-shaped CD68+lysozyme-CD163+ cells. Cervical lymph node was infiltrated mainly by population (A), where chemotherapy was quite effective. On the other hand, vast majority of infiltrated tumor cells in the hilar lymph node belonged to population (B), in which the cells were resistant to chemo-radiotherapy. Considering the poor prognosis of HS, the expression of CD163 could be a marker for resistance to chemo-radiotherapy. It is also notable that CD163-negative stage of HS may exist and still be reactive for the treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924729     DOI: 10.1007/s12185-010-0699-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  31 in total

1.  Histiocytic sarcoma and underlying chronic myelomonocytic leukemia: a proposal for the developmental classification of histiocytic sarcoma.

Authors:  Minako Mori; Akiko Matsushita; Yohko Takiuchi; Hiroshi Arima; Seiji Nagano; Sonoko Shimoji; Takaharu Kimura; Daichi Inoue; Sumie Tabata; Sohshi Yanagita; Kenichi Nagai; Yukihiro Imai; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2010-06-10       Impact factor: 2.490

2.  The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria.

Authors:  Babs O Fabriek; Robin van Bruggen; Dong Mei Deng; Antoon J M Ligtenberg; Kamran Nazmi; Karin Schornagel; Rianka P M Vloet; Christine D Dijkstra; Timo K van den Berg
Journal:  Blood       Date:  2008-10-10       Impact factor: 22.113

3.  Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163).

Authors:  P Högger; J Dreier; A Droste; F Buck; C Sorg
Journal:  J Immunol       Date:  1998-08-15       Impact factor: 5.422

Review 4.  Association between mediastinal germ cell tumors and hematologic malignancies: an update.

Authors:  S H deMent
Journal:  Hum Pathol       Date:  1990-07       Impact factor: 3.466

5.  Identification of the haemoglobin scavenger receptor.

Authors:  M Kristiansen; J H Graversen; C Jacobsen; O Sonne; H J Hoffman; S K Law; S K Moestrup
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

6.  The rat macrophage scavenger receptor CD163: expression, regulation and role in inflammatory mediator production.

Authors:  Machteld M J Polfliet; Babs O Fabriek; Wouter P Daniëls; Christine D Dijkstra; Timo K van den Berg
Journal:  Immunobiology       Date:  2006-07-24       Impact factor: 3.144

7.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Authors:  S A Pileri; T M Grogan; N L Harris; P Banks; E Campo; J K C Chan; R D Favera; G Delsol; C De Wolf-Peeters; B Falini; R D Gascoyne; P Gaulard; K C Gatter; P G Isaacson; E S Jaffe; P Kluin; D M Knowles; D Y Mason; S Mori; H-K Müller-Hermelink; M A Piris; E Ralfkiaer; H Stein; I-J Su; R A Warnke; L M Weiss
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

8.  Malignant histiocytoses/disseminated histiocytic sarcoma with hemophagocytic syndrome in a patient with mediastinal germ cell tumor.

Authors:  Hiroko Shinoda; Akihiko Yoshida; Julie Teruya-Feldstein
Journal:  Appl Immunohistochem Mol Morphol       Date:  2009-07

9.  A case of primary histiocytic sarcoma arising from thyroid gland.

Authors:  Lu Yu; Shou Jing Yang
Journal:  Pathol Oncol Res       Date:  2009-08-05       Impact factor: 3.201

10.  Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.

Authors:  Muneer H Abidi; Isaacson Tove; Rami B Ibrahim; Dan Maria; Edward Peres
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047

View more
  2 in total

1.  Morphological Distinction of Histiocytic Sarcoma from Other Tumor Types in Bernese Mountain Dogs and Flatcoated Retrievers.

Authors:  Suzanne A Erich; Fernando Constantino-Casas; Jane M Dobson; Erik Teske
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

2.  RNA in situ hybridisation as a molecular diagnostic technique targeting IBA-1 and CD204 in canine histiocytic sarcoma.

Authors:  Julia L Engelien; Amandine T Lejeune; Michael J Dark; Rowan J Milner; Keijiro Shiomitsu
Journal:  Vet Med Sci       Date:  2022-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.